152 related articles for article (PubMed ID: 8244657)
21. Sustained improvement of performance and haemodynamics with long-term aerosolised prostacyclin therapy in severe pulmonary hypertension.
Stricker H; Domenighetti G; Fiori G; Mombelli G
Schweiz Med Wochenschr; 1999 Jun; 129(24):923-7. PubMed ID: 10413827
[TBL] [Abstract][Full Text] [Related]
22. Continuous intravenous epoprostenol in pulmonary hypertension: the Israel experience.
Bendayan D; Fink G; Aravot D; Ygla M; Bendov I; Bliden L; Nir A; Kramer MR
Isr Med Assoc J; 2002 Apr; 4(4):255-8. PubMed ID: 12001697
[TBL] [Abstract][Full Text] [Related]
23. Unpredictable response to vasodilator therapy in primary pulmonary hypertension.
Schmiedt MI; Shettigar UR; Siddique M; Barbier G; Bialow M; Carranza S
Int J Clin Pharmacol Ther; 1998 Aug; 36(8):435-40. PubMed ID: 9726697
[TBL] [Abstract][Full Text] [Related]
24. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin.
Barst RJ; Rubin LJ; McGoon MD; Caldwell EJ; Long WA; Levy PS
Ann Intern Med; 1994 Sep; 121(6):409-15. PubMed ID: 8053614
[TBL] [Abstract][Full Text] [Related]
25. The role of prostacyclin in the treatment of primary pulmonary hypertension: the Cambridge experience.
Cremona G
Cardiologia; 1993 Dec; 38(12 Suppl 1):227-32. PubMed ID: 8020021
[TBL] [Abstract][Full Text] [Related]
26. [Continuous intravenous prostacyclin therapy].
Miyaji K; Matsubara H
Nihon Rinsho; 2008 Nov; 66(11):2139-44. PubMed ID: 19051733
[TBL] [Abstract][Full Text] [Related]
27. Effects of long-term infusion of prostacyclin on exercise performance in patients with primary pulmonary hypertension.
Wax D; Garofano R; Barst RJ
Chest; 1999 Oct; 116(4):914-20. PubMed ID: 10531153
[TBL] [Abstract][Full Text] [Related]
28. [Clinical study on long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol infusion].
Cao TS; Yuan LJ; Duan YY; Wang ZJ; Zhuang L; Shapiro SM; Brundage BH
Zhonghua Nei Ke Za Zhi; 2003 Feb; 42(2):106-9. PubMed ID: 12783707
[TBL] [Abstract][Full Text] [Related]
29. Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin).
Jones DK; Higenbottam TW; Wallwork J
Br Heart J; 1987 Mar; 57(3):270-8. PubMed ID: 3552006
[TBL] [Abstract][Full Text] [Related]
30. Long-term prostacyclin infusion to reduce pulmonary hypertension in a pediatric cardiac transplant candidate prior to transplantation.
Kao B; Balzer DT; Huddleston CB; Canter CE
J Heart Lung Transplant; 2001 Jul; 20(7):785-8. PubMed ID: 11448812
[TBL] [Abstract][Full Text] [Related]
31. Primary pulmonary hypertension. An analysis of 28 cases and a review of the literature.
Hughes JD; Rubin LJ
Medicine (Baltimore); 1986 Jan; 65(1):56-72. PubMed ID: 2867454
[TBL] [Abstract][Full Text] [Related]
32. Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension.
Rubin LJ; Groves BM; Reeves JT; Frosolono M; Handel F; Cato AE
Circulation; 1982 Aug; 66(2):334-8. PubMed ID: 7046988
[TBL] [Abstract][Full Text] [Related]
33. [Definition, concept and pathophysiology of pulmonary hypertension].
Kunieda T
Nihon Rinsho; 2001 Jun; 59(6):1037-46. PubMed ID: 11411110
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertension.
Raffy O; Azarian R; Brenot F; Parent F; Sitbon O; Petitpretz P; Hervé P; Duroux P; Dinh-Xuan AT; Simonneau G
Circulation; 1996 Feb; 93(3):484-8. PubMed ID: 8565165
[TBL] [Abstract][Full Text] [Related]
35. The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension.
Rich S; McLaughlin VV
J Am Coll Cardiol; 1999 Oct; 34(4):1184-7. PubMed ID: 10520810
[TBL] [Abstract][Full Text] [Related]
36. Reduction of acute pulmonary hypertension by prostacyclin.
Borchert J; Franke J; Lichey J
Cor Vasa; 1980; 22(4):281-7. PubMed ID: 7004773
[TBL] [Abstract][Full Text] [Related]
37. Effects of continuous intravenous epoprostenol therapy on advanced primary pulmonary hypertension in Taiwanese patients.
Hsu HH; Chen JS; Kuo SH; Chiang FT; Ko WJ; Kuo SW; Huang SC; Lee YC
J Formos Med Assoc; 2005 Jan; 104(1):60-3. PubMed ID: 15660181
[TBL] [Abstract][Full Text] [Related]
38. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial.
Rubin LJ; Mendoza J; Hood M; McGoon M; Barst R; Williams WB; Diehl JH; Crow J; Long W
Ann Intern Med; 1990 Apr; 112(7):485-91. PubMed ID: 2107780
[TBL] [Abstract][Full Text] [Related]
39. Primary pulmonary hypertension. Practical therapeutic recommendations.
Rubin LJ
Drugs; 1992 Jan; 43(1):37-43. PubMed ID: 1372858
[TBL] [Abstract][Full Text] [Related]
40. Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension.
Nagaya N; Uematsu M; Okano Y; Satoh T; Kyotani S; Sakamaki F; Nakanishi N; Miyatake K; Kunieda T
J Am Coll Cardiol; 1999 Oct; 34(4):1188-92. PubMed ID: 10520811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
